Immuneering

IMRX

Market cap $436M

6.89 USD

+0.27

4.08%

At close Updated Nov 7, 4:00 PM EST

Pre-market

After hours

6.94

+0.05

0.73%

1 day

4.08%

5 days

2.07%

1 month

12.77%

3 months

96.3%

6 months

526.36%

Year to date

211.76%

1 year

256.99%

5 years

-60.83%

10 years

-60.83%

About: Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Employees: 54

Healthcare Biotechnology